Skye Bioscience, Inc.: Clinical Trials

2 trials sponsored by Skye Bioscience, Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Active not recruiting 1, Completed 1

Follow Skye Bioscience, Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Evaluate the Effect on Obesity of QW Nimacimab and QW Nimacimab Co-administered With Semaglutide vs Placebo
Nimacimab injection, Nimacimab placebo injection, semaglutide injection - Obesity
Phase 2Active not recruitingSkye Bioscience, Inc.1362024-08-222026-01-14
Ph2 Placebo-Controlled Study for Safety & Ocular Efficacy of SBI-100 Ophthalmic Emulsion in Pts w/ Elevated Eye Pressure
SBI-100 Ophthalmic Emulsion, 0.5%, SBI-100 Ophthalmic Emulsion, 1.0%, SBI-100 Ophthalmic Emulsion, Placebo - Primary Open Angle Glaucoma, Ocular Hypertension
Phase 2CompletedSkye Bioscience, Inc.562023-11-092026-01-14

Conditions studied

Glaucoma (1)  ·  Glaucoma, Open-Angle (1)  ·  Obesity (1)  ·  Ocular Hypertension (1)

Interventions

Injections (1)  ·  semaglutide (1)

Countries

United States (2)

Top investigators

Tu Diep (1)